JP2012506702A - 非ウイルス性再プログラムによる多能性幹細胞 - Google Patents

非ウイルス性再プログラムによる多能性幹細胞 Download PDF

Info

Publication number
JP2012506702A
JP2012506702A JP2011533384A JP2011533384A JP2012506702A JP 2012506702 A JP2012506702 A JP 2012506702A JP 2011533384 A JP2011533384 A JP 2011533384A JP 2011533384 A JP2011533384 A JP 2011533384A JP 2012506702 A JP2012506702 A JP 2012506702A
Authority
JP
Japan
Prior art keywords
promoter
vector
cells
ires2
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011533384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506702A5 (enExample
Inventor
ジェイムズ トムソン
ジュンイン ユ
Original Assignee
ウイスコンシン アラムニ リサーチ ファンデーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2012506702(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ウイスコンシン アラムニ リサーチ ファンデーション filed Critical ウイスコンシン アラムニ リサーチ ファンデーション
Publication of JP2012506702A publication Critical patent/JP2012506702A/ja
Publication of JP2012506702A5 publication Critical patent/JP2012506702A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/605—Nanog
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/606—Transcription factors c-Myc
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/608—Lin28
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2011533384A 2008-10-24 2009-10-23 非ウイルス性再プログラムによる多能性幹細胞 Withdrawn JP2012506702A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10836208P 2008-10-24 2008-10-24
US61/108,362 2008-10-24
PCT/US2009/061935 WO2010048567A1 (en) 2008-10-24 2009-10-23 Pluripotent stem cells obtained by non-viral reprogramming

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015165051A Division JP6312638B2 (ja) 2008-10-24 2015-08-24 非ウイルス性再プログラムによる多能性幹細胞

Publications (2)

Publication Number Publication Date
JP2012506702A true JP2012506702A (ja) 2012-03-22
JP2012506702A5 JP2012506702A5 (enExample) 2014-12-25

Family

ID=41698343

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011533384A Withdrawn JP2012506702A (ja) 2008-10-24 2009-10-23 非ウイルス性再プログラムによる多能性幹細胞
JP2015165051A Active JP6312638B2 (ja) 2008-10-24 2015-08-24 非ウイルス性再プログラムによる多能性幹細胞
JP2016165793A Pending JP2016220686A (ja) 2008-10-24 2016-08-26 非ウイルス性再プログラムによる多能性幹細胞
JP2018155983A Active JP6861189B2 (ja) 2008-10-24 2018-08-23 非ウイルス性再プログラムによる多能性幹細胞
JP2021055183A Active JP7165228B2 (ja) 2008-10-24 2021-03-29 非ウイルス性再プログラムによる多能性幹細胞

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015165051A Active JP6312638B2 (ja) 2008-10-24 2015-08-24 非ウイルス性再プログラムによる多能性幹細胞
JP2016165793A Pending JP2016220686A (ja) 2008-10-24 2016-08-26 非ウイルス性再プログラムによる多能性幹細胞
JP2018155983A Active JP6861189B2 (ja) 2008-10-24 2018-08-23 非ウイルス性再プログラムによる多能性幹細胞
JP2021055183A Active JP7165228B2 (ja) 2008-10-24 2021-03-29 非ウイルス性再プログラムによる多能性幹細胞

Country Status (10)

Country Link
US (4) US8268620B2 (enExample)
EP (2) EP3450545B1 (enExample)
JP (5) JP2012506702A (enExample)
CN (2) CN102239249A (enExample)
CA (1) CA2741090C (enExample)
DK (2) DK2356221T3 (enExample)
ES (1) ES2959327T3 (enExample)
IL (1) IL212433B (enExample)
SG (1) SG10201600234PA (enExample)
WO (1) WO2010048567A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017012145A (ja) * 2015-07-02 2017-01-19 株式会社豊田中央研究所 遺伝的組換えを誘発する方法及びその利用
US10260048B2 (en) 2010-06-15 2019-04-16 FUJIFILM Cellular Dynamics, Inc. Generation of induced pluripotent stem cells from small volumes of peripheral blood
JP2021094040A (ja) * 2008-10-24 2021-06-24 ウイスコンシン アラムニ リサーチ ファンデーション 非ウイルス性再プログラムによる多能性幹細胞

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101420740B1 (ko) 2005-12-13 2014-07-17 교또 다이가꾸 핵초기화 인자
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US20090227032A1 (en) * 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2137296A2 (en) 2007-03-23 2009-12-30 Wisconsin Alumni Research Foundation Somatic cell reprogramming
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
ES2722198T3 (es) 2008-05-02 2019-08-08 Univ Kyoto Método de reprogramación nuclear
EP3447128A1 (en) 2008-06-04 2019-02-27 FUJIFILM Cellular Dynamics, Inc. Methods for the production of ips cells using non-viral approach
CN102171348A (zh) * 2008-08-12 2011-08-31 细胞动力国际有限公司 产生ips细胞的方法
CN103087991B (zh) 2009-06-05 2018-06-12 富士胶片细胞动力公司 重编程t细胞和造血细胞的方法
US8048675B1 (en) * 2010-05-12 2011-11-01 Ipierian, Inc. Integration-free human induced pluripotent stem cells from blood
US9279107B2 (en) 2010-08-05 2016-03-08 Wisconsin Alumni Research Foundation Simplified basic media for human pluripotent cell culture
KR101829488B1 (ko) * 2010-08-05 2018-02-14 위스콘신 얼럼나이 리서어치 화운데이션 인간 다분화능 세포 배양을 위한 단순화된 기본 배지
JP2013545439A (ja) 2010-09-17 2013-12-26 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 多能性幹細胞の有用性および安全性の特徴決定を行うための機能的ゲノミクスアッセイ
EP4086338A1 (en) 2011-03-17 2022-11-09 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
US9133266B2 (en) 2011-05-06 2015-09-15 Wisconsin Alumni Research Foundation Vitronectin-derived cell culture substrate and uses thereof
JP2014520551A (ja) * 2011-07-11 2014-08-25 セルラー ダイナミクス インターナショナル， インコーポレイテッド 細胞のリプログラミング方法およびゲノムの改変方法
WO2013059373A2 (en) 2011-10-17 2013-04-25 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
WO2013074916A1 (en) 2011-11-18 2013-05-23 Board Of Regents, The University Of Texas System Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
US8497124B2 (en) 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
DK3260140T3 (da) 2011-12-05 2021-04-19 Factor Bioscience Inc Fremgangsmåder og produkter til transficering af celler
US8772460B2 (en) 2011-12-16 2014-07-08 Wisconsin Alumni Research Foundation Thermostable FGF-2 mutant having enhanced stability
US20130266541A1 (en) * 2012-04-06 2013-10-10 The Johns Hopkins University Human induced pluripotent stem cells
BR122019025681B1 (pt) 2012-11-01 2023-04-18 Factor Bioscience Inc Método para inserir uma sequência de ácido nucleico em uma localização segura de um genoma de uma célula
US20150368713A1 (en) 2013-02-01 2015-12-24 THE UNITED STATES OF AMERICAN, as represented by the Secretary, Department of Health and Human Serv METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs)
JP6697380B2 (ja) 2013-06-10 2020-05-20 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 多能性幹細胞の有用性および安全性を特徴付けるための初期発生ゲノムアッセイ
WO2015006725A2 (en) 2013-07-12 2015-01-15 Cedars-Sinai Medical Center Generation of induced pluripotent stem cells from normal human mammary epithelial cells
KR101551926B1 (ko) 2013-09-06 2015-09-10 가톨릭대학교 산학협력단 인간 유래 역분화 줄기세포 및 이를 이용한 인간의 면역계가 발현된 동물 제조 방법
US11377639B2 (en) 2013-11-15 2022-07-05 Wisconsin Alumni Research Foundation Lineage reprogramming to induced cardiac progenitor cells (iCPC) by defined factors
WO2015117021A1 (en) 2014-01-31 2015-08-06 Factor Bioscience Inc. Methods and products for nucleic acid production and delivery
CA2945393C (en) * 2014-04-24 2021-03-23 Board Of Regents, The University Of Texas System Application of induced pluripotent stem cells to generate adoptive cell therapy products
EP4427809A3 (en) 2014-10-31 2024-12-04 The Trustees of The University of Pennsylvania Altering gene expression in car-t cells and uses thereof
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
RU2730034C2 (ru) * 2015-04-14 2020-08-14 Киото Юниверсити Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки
AU2016318774B2 (en) 2015-09-08 2022-08-18 FUJIFILM Cellular Dynamics, Inc. MACS-based purification of stem cell-derived retinal pigment epithelium
ES2970537T3 (es) 2015-09-08 2024-05-29 Us Health Método para la diferenciación reproducible de células epiteliales del pigmento retiniano de calidad clínica
CN105219729B (zh) * 2015-09-28 2018-09-25 首都医科大学宣武医院 一种利用非整合质粒载体诱导神经干细胞的方法及其用途
US10865381B2 (en) 2015-10-20 2020-12-15 FUJIFILM Cellular Dynamics, Inc. Multi-lineage hematopoietic precursor cell production by genetic programming
WO2017196175A1 (en) 2016-05-12 2017-11-16 Erasmus University Medical Center Rotterdam A method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium.
CN105861447B (zh) * 2016-06-13 2017-12-19 广州市搏克生物技术有限公司 一种非病毒iPSCs诱导组合物及其试剂盒
US11572545B2 (en) 2016-06-16 2023-02-07 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
US10221395B2 (en) 2016-06-16 2019-03-05 Cedars-Sinai Medical Center Efficient method for reprogramming blood to induced pluripotent stem cells
US20180030478A1 (en) 2016-07-01 2018-02-01 Research Development Foundation Elimination of proliferating cells from stem cell-derived grafts
WO2018026723A1 (en) 2016-08-01 2018-02-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Human induced pluripotent stem cells for high efficiency genetic engineering
CN109803977B (zh) 2016-08-17 2023-03-17 菲克特生物科学股份有限公司 核酸产品及其施用方法
ES3009605T3 (en) 2016-10-05 2025-03-27 Fujifilm Cellular Dynamics Inc Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
WO2018089515A1 (en) 2016-11-09 2018-05-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 3d vascularized human ocular tissue for cell therapy and drug discovery
JP7088564B2 (ja) 2016-11-10 2022-06-21 ヴィアサイト，インコーポレイテッド 細胞送達装置におけるｐｄｘ１膵臓内胚葉細胞及びその方法
WO2018152120A1 (en) 2017-02-14 2018-08-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of engineering human induced pluripotent stem cells to produce liver tissue
MX2019011897A (es) 2017-04-18 2019-11-28 Fujifilm Cellular Dynamics Inc Celulas efectoras inmunitarias especificas de antigenos.
WO2018232079A1 (en) 2017-06-14 2018-12-20 Daley George Q Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer
US10760057B2 (en) 2017-07-06 2020-09-01 Wisconsin Alumni Research Foundation Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease
NL2019517B1 (en) 2017-09-08 2019-03-19 Univ Erasmus Med Ct Rotterdam New therapy for Pompe disease
EP3692139B1 (en) 2017-10-03 2024-11-06 SDF BioPharma Inc. Treating diabetes with genetically modified beta cells
AU2019256723B2 (en) 2018-04-20 2025-09-04 FUJIFILM Cellular Dynamics, Inc. Method for differentiation of ocular cells and use thereof
CA3109546A1 (en) 2018-09-07 2020-03-12 Wisconsin Alumni Research Foundation Generation of hematopoietic progenitor cells from human pluripotent stem cells
KR20210095885A (ko) 2018-11-19 2021-08-03 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 생분해성 조직 대체 임플란트 및 그의 용도
AU2019386140A1 (en) 2018-11-28 2021-06-24 Board Of Regents, The University Of Texas System Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment
CN113316455A (zh) 2018-11-29 2021-08-27 得克萨斯大学体系董事会 用于离体扩增自然杀伤细胞的方法及其用途
WO2021003462A1 (en) 2019-07-03 2021-01-07 Factor Bioscience Inc. Cationic lipids and uses thereof
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
AU2021235185A1 (en) 2020-03-09 2022-11-03 Fujifilm Corporation Markers specific for pluripotent stem cells, and methods of using the same
JP2023528377A (ja) 2020-05-29 2023-07-04 フジフィルム セルラー ダイナミクス，インコーポレイテッド 網膜色素上皮及び光受容体の二重細胞凝集体、並びにその使用方法
US20230212509A1 (en) 2020-05-29 2023-07-06 FUJIFILM Cellular Dynamics, Inc. Bilayer of retinal pigmented epithelium and photoreceptors and use thereof
EP3922431A1 (en) 2020-06-08 2021-12-15 Erasmus University Medical Center Rotterdam Method of manufacturing microdevices for lab-on-chip applications
AU2021377699A1 (en) 2020-11-13 2023-06-15 Catamaran Bio, Inc. Genetically modified natural killer cells and methods of use thereof
JP2023550453A (ja) 2020-11-18 2023-12-01 富士フイルム株式会社 セクレトーム含有組成物の生成、並びにその使用及び分析方法
AU2021388155A1 (en) 2020-11-25 2023-06-15 Catamaran Bio, Inc. Cellular therapeutics engineered with signal modulators and methods of use thereof
JP2024519515A (ja) 2021-04-07 2024-05-15 センチュリー セラピューティクス，インコーポレイテッド 人工多能性幹細胞からガンマ－デルタｔ細胞を生成するための組成物および方法
CN117441010A (zh) 2021-04-07 2024-01-23 世纪治疗股份有限公司 从诱导多能干细胞产生α-βT细胞的组合物和方法
KR20240011831A (ko) 2021-05-26 2024-01-26 후지필름 셀룰러 다이내믹스, 인코포레이티드 만능 줄기 세포에서 유전자의 신속한 사일런싱을 방지하기 위한 방법
US20240271089A1 (en) 2021-05-28 2024-08-15 The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Methods to generate macular, central and peripheral retinal pigment epithelial cells
US20240261474A1 (en) 2021-05-28 2024-08-08 The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Biodegradable tissue scaffold with secondary matrix to host weakly adherent cells
JP2024531682A (ja) 2021-09-13 2024-08-29 フジフィルム セルラー ダイナミクス，インコーポレイテッド コミットされた心臓始原細胞の製造方法
WO2023172514A1 (en) 2022-03-07 2023-09-14 Catamaran Bio, Inc. Engineered immune cell therapeutics targeted to her2 and methods of use thereof
CN119630695A (zh) 2022-06-08 2025-03-14 世纪治疗股份有限公司 表达cd16变体和nkg2d的遗传工程化细胞及其用途
US20240003871A1 (en) 2022-06-29 2024-01-04 FUJIFILM Cellular Dynamics, Inc. Ipsc-derived astrocytes and methods of use thereof
WO2024073776A1 (en) 2022-09-30 2024-04-04 FUJIFILM Cellular Dynamics, Inc. Methods for the production of cardiac fibroblasts
WO2024192329A1 (en) 2023-03-16 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for producing stable human chondroctyes and their use for promoting cartillage growth and repair
WO2025208002A1 (en) * 2024-03-28 2025-10-02 Altos Labs, Inc. Targeted expression of regeneration factors in aged/senescent cells
WO2025245202A1 (en) 2024-05-21 2025-11-27 FUJIFILM Cellular Dynamics, Inc. Particle counting and biomass measurements of aggregated cell compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003506075A (ja) * 1999-08-05 2003-02-18 エムシーエル エルエルシー 多能性成人幹細胞およびそれを単離する方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223084D0 (en) 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
CA2515108A1 (en) 2003-02-07 2004-08-26 Wisconsin Alumni Research Foundation Directed genetic modifications of human stem cells
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2137296A2 (en) * 2007-03-23 2009-12-30 Wisconsin Alumni Research Foundation Somatic cell reprogramming
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
EP2072618A1 (en) 2007-12-14 2009-06-24 Johannes Gutenberg-Universität Mainz Use of RNA for reprogramming somatic cells
CN101250502A (zh) * 2008-04-01 2008-08-27 中国科学院上海生命科学研究院 一种诱导的多潜能干细胞的制备方法
ES2722198T3 (es) * 2008-05-02 2019-08-08 Univ Kyoto Método de reprogramación nuclear
EP3447128A1 (en) * 2008-06-04 2019-02-27 FUJIFILM Cellular Dynamics, Inc. Methods for the production of ips cells using non-viral approach
WO2009157201A1 (en) * 2008-06-26 2009-12-30 Osaka University Method and kit for preparing ips cells
WO2010012077A1 (en) 2008-07-28 2010-02-04 Mount Sinai Hospital Compositions, methods and kits for reprogramming somatic cells
EP3450545B1 (en) * 2008-10-24 2023-08-23 Wisconsin Alumni Research Foundation Pluripotent stem cells obtained by non-viral reprogramming

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003506075A (ja) * 1999-08-05 2003-02-18 エムシーエル エルエルシー 多能性成人幹細胞およびそれを単離する方法

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JPN6013061508; ＲＥＮ，Ｃ．　ｅｔ　ａｌ．: 'Ｅｓｔａｂｌｉｓｈｍｅｎｔ　ａｎｄ　ａｐｐｌｉｃａｔｉｏｎｓ　ｏｆ　ｅｐｓｔｅｉｎ-ｂａｒｒ　ｖｉｒｕｓ-ｂａｓｅｄ　ｅｐｉｓｏｍａｌ　ｖｅｃｔｏｒｓ　ｉｎ　ｈｕｍａｎ　ｅｍｂｒｙｏｎｉｃ　ｓｔｅｍ' Ｓｔｅｍ　Ｃｅｌｌｓ Ｖｏｌ．２４，　Ｎｏ．５, 200605, ｐｐ．１３３８-４７ *
JPN6014018592; Ｓｃｉｅｎｃｅ Ｖｏｌ．３１８, 2007, ｐ．１９１７-１９２０ *
JPN6014018594; Ｓｃｉｅｎｃｅ Ｖｏｌ．３２２, 20081009, ｐ．９４９-９５３ *
JPN6014018597; Ｎａｔｕｒｅ Ｖｏｌ．４５１, 2007, ｐ．１４１-１４７ *
JPN6015015668; Ｍｏｌｅｃｕｌａｒ　Ｂｉｏｌｏｇｙ　Ｒｅｐｏｒｔｓ Ｖｏｌ．３１, 2004, ｐ．８５-９０ *
JPN6015015670; ＰＮＡＳ Ｖｏｌ．１０３，　Ｎｏ．４７, 2006, ｐ．１７６７２-１７６７７ *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021094040A (ja) * 2008-10-24 2021-06-24 ウイスコンシン アラムニ リサーチ ファンデーション 非ウイルス性再プログラムによる多能性幹細胞
JP7165228B2 (ja) 2008-10-24 2022-11-02 ウイスコンシン アラムニ リサーチ ファンデーション 非ウイルス性再プログラムによる多能性幹細胞
US10260048B2 (en) 2010-06-15 2019-04-16 FUJIFILM Cellular Dynamics, Inc. Generation of induced pluripotent stem cells from small volumes of peripheral blood
JP2017012145A (ja) * 2015-07-02 2017-01-19 株式会社豊田中央研究所 遺伝的組換えを誘発する方法及びその利用
US11464182B2 (en) 2015-07-02 2022-10-11 Kabushiki Kaisha Toyota Chuo Kenkyusho Method of inducing genetic recombination, and use therefor

Also Published As

Publication number Publication date
US20190330654A1 (en) 2019-10-31
WO2010048567A1 (en) 2010-04-29
CN105802917A (zh) 2016-07-27
IL212433B (en) 2019-08-29
JP2018174945A (ja) 2018-11-15
JP7165228B2 (ja) 2022-11-02
DK2356221T3 (en) 2019-02-18
US20220010331A1 (en) 2022-01-13
CN102239249A (zh) 2011-11-09
CA2741090C (en) 2018-10-16
US8268620B2 (en) 2012-09-18
US20130217117A1 (en) 2013-08-22
EP2356221B1 (en) 2018-11-21
JP6312638B2 (ja) 2018-04-18
SG10201600234PA (en) 2016-02-26
DK3450545T5 (da) 2024-09-09
JP2015213522A (ja) 2015-12-03
IL212433A0 (en) 2011-06-30
CA2741090A1 (en) 2010-04-29
EP3450545B1 (en) 2023-08-23
ES2959327T3 (es) 2024-02-23
DK3450545T3 (da) 2023-10-02
EP3450545A1 (en) 2019-03-06
JP2021094040A (ja) 2021-06-24
EP2356221A1 (en) 2011-08-17
JP6861189B2 (ja) 2021-04-21
JP2016220686A (ja) 2016-12-28
US20100184227A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
JP7165228B2 (ja) 非ウイルス性再プログラムによる多能性幹細胞
JP5813321B2 (ja) 体細胞の再プログラム化
US9850499B2 (en) Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells
Eminli et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression
US10435711B2 (en) Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
JP6530452B2 (ja) 合成メッセンジャーｒｎａを使用したヒト人工多能性幹細胞のフィーダーフリー誘導
CN102190731B (zh) 用人工转录因子诱导产生多能干细胞
JP2016521541A (ja) 合成メッセンジャーｒｎａによるヒト人工多能性幹細胞のフィーダーフリー誘導
Pfaff et al. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells
KR102361849B1 (ko) 합성 메신저 rna를 사용한 인간-유도된 만능 줄기 세포의 무-피더 유래
JP2019170405A (ja) 合成メッセンジャーｒｎａによるヒト人工多能性幹細胞のフィーダーフリー誘導
MAHMAUD GENERATION OF MOUSE INDUCED PLURIPOTENT STEM CELLS USING POLYCISTRONIC LENTIVIRAL VECTOR IN FEEDER-AND SERUM-FREE CULTURE

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140807

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140814

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20141107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150422

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150824

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150924

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20151019

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20151218

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20160404